Tibra Equities Europe’s XBiotech XBIT Stock Holding History

Tibra Equities Europe’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-68,047	Closed	-$750K	–	444
2019 Q1	$750K	Buy	+68,047	New	+$552K	0.07%	207

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Tibra Equities Europe's XBIT Position: Q2 2019 in Review

Tibra Equities Europe sold out of XBiotech (XBIT) in Q2 2019, closing a stake of 68,047 shares — an estimated $750K sold.

Tibra Equities Europe first reported a position in XBIT in Q1 2019 and held it in 1 quarter. The position peaked at $750K in Q1 2019. 43 funds tracked by Wall St. Rank hold XBIT as of Q2 2019.

Tibra Equities Europe reported no remaining XBiotech position as of Q2 2019 after selling out during the quarter.
Tibra Equities Europe sold 68,047 XBiotech shares in Q2 2019, an estimated $750K.
Tibra Equities Europe first reported a position in XBiotech in Q1 2019 and held it in 1 quarter.
Tibra Equities Europe's XBiotech position peaked at $750K in Q1 2019.
43 funds tracked by Wall St. Rank held XBiotech as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.